{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:23:16Z","timestamp":1793146996536,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoporosis and Sarcopenia"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.afos.2023.06.002","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T09:48:05Z","timestamp":1687254485000},"page":"60-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A summary of the Malaysian Clinical Practice Guidelines on the management of postmenopausal osteoporosis, 2022"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7473-446X","authenticated-orcid":false,"given":"Terence Ing Wei","family":"Ong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-6924","authenticated-orcid":false,"given":"Lee Ling","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew Pheng","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie Siew Swee","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3081-4182","authenticated-orcid":false,"given":"Alan Swee Hock","family":"Ch\u2019ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth Gar Mit","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8886-1953","authenticated-orcid":false,"given":"Premitha","family":"Damodaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen Lee","family":"Hew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luqman bin","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Min","family":"Khor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-9644","authenticated-orcid":false,"given":"Pauline Siew Mei","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4215-1689","authenticated-orcid":false,"given":"Joon Kiong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai Lee","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boon Ping","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3470-7015","authenticated-orcid":false,"given":"Sharmila Sunita","family":"Paramasivam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyakantha","family":"Ratnasingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yew Siong","family":"Siow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander Tong Boon","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagammai","family":"Thiagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0474-3667","authenticated-orcid":false,"given":"Swan Sim","family":"Yeap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.afos.2023.06.002_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"American association of clinical endocrinologists\/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update","volume":"26","author":"Camacho","year":"2020","journal-title":"Endocr Pract"},{"key":"10.1016\/j.afos.2023.06.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115286","article-title":"Risk of major osteoporotic fracture after first, second and third fracture in Swedish women aged 50 years and older","volume":"134","author":"S\u00f6reskog","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.afos.2023.06.002_bib3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.afos.2018.03.003","article-title":"An updated hip fracture projection in Asia: the Asian Federation of Osteoporosis Societies study","volume":"4","author":"Cheung","year":"2018","journal-title":"Osteoporos Sarcopenia"},{"key":"10.1016\/j.afos.2023.06.002_bib4","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"National osteoporosis foundation. Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jocd.2019.07.001","article-title":"Executive summary of the 2019 ISCD position development conference on monitoring treatment, DXA cross-calibration and least significant change, spinal cord injury, peri-prosthetic and orthopedic bone health, transgender medicine, and pediatrics","volume":"22","author":"Shuhart","year":"2019","journal-title":"J Clin Densitom"},{"key":"10.1016\/j.afos.2023.06.002_bib9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s00198-020-05742-0","article-title":"Development of the Asia Pacific Consortium on Osteoporosis (APCO) Framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asia-Pacific region","volume":"32","author":"Chandran","year":"2021","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s001980170070","article-title":"A simple tool to identify Asian women at increased risk of osteoporosis","volume":"12","author":"Koh","year":"2001","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.srhc.2010.11.004","article-title":"Developing a Malaysian Osteoporosis Screening Tool (MOST) for early osteoporosis detection in Malaysian women","volume":"2","author":"Shan","year":"2011","journal-title":"Sex Reprod Healthc"},{"key":"10.1016\/j.afos.2023.06.002_bib12","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib13","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00198-015-3440-3","article-title":"The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib14","article-title":"Calcium intake and bone mineral density: systematic review and meta-analysis","volume":"351","author":"Tai","year":"2015","journal-title":"Br Med J"},{"key":"10.1016\/j.afos.2023.06.002_bib15","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/ajcn\/86.5.1780","article-title":"Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials","volume":"86","author":"Bischoff-Ferrari","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.afos.2023.06.002_bib16","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)61342-7","article-title":"Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a metaanalysis","volume":"370","author":"Tang","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.afos.2023.06.002_bib17","doi-asserted-by":"crossref","first-page":"h4580","DOI":"10.1136\/bmj.h4580","article-title":"Calcium intake and risk of fracture: systematic review","volume":"351","author":"Bolland","year":"2015","journal-title":"Br Med J"},{"key":"10.1016\/j.afos.2023.06.002_bib19","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000021506","article-title":"Vitamin D supplement on prevention of fall and fracture: a meta-analysis of randomized controlled trials","volume":"99","author":"Thanapluetiwong","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.afos.2023.06.002_bib20","doi-asserted-by":"crossref","first-page":"b5463","DOI":"10.1136\/bmj.b5463","article-title":"DIPART (Vitamin D Individual Patient Analysis of Randomized Trials) Group. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe","volume":"340","year":"2010","journal-title":"Br Med J"},{"key":"10.1016\/j.afos.2023.06.002_bib21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00198-016-3773-6","volume":"28","author":"Harvey","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib22","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00198-009-0938-6","article-title":"Exercise interventions to reduce fall-related fractures and their risk factors in individuals with low bone density: a systematic review of randomized controlled trials","volume":"20","author":"de Kam","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1359\/jbmr.2003.18.1.156","article-title":"Regional specificity of exercise and calcium during skeletal growth in girls: a randomized controlled trial","volume":"18","author":"Iuliano-Burns","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.06.002_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/JSM.0b013e318032129d","article-title":"The bone response to non-weight-bearing exercise is sport-, site-, and sex-specific","volume":"17","author":"Magkos","year":"2007","journal-title":"Clin J Sport Med"},{"key":"10.1016\/j.afos.2023.06.002_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12966-020-01041-3","article-title":"Evidence on physical activity and falls prevention for people aged 65+ years: systematic review to inform the WHO guidelines on physical activity and sedentary behaviour","volume":"17","author":"Sherrington","year":"2020","journal-title":"Int J Behav Nutr Phys Activ"},{"key":"10.1016\/j.afos.2023.06.002_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12877-019-1359-9","article-title":"The efficacy and safety of exercise for prevention of fall-related injuries in older people with different health conditions, and differing intervention protocols: a meta-analysis of randomized controlled trials","volume":"19","author":"Zhao","year":"2019","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.afos.2023.06.002_bib27","series-title":"Interventions to prevent falls in community-dwelling older adults: a systematic review for the U.S. Preventive services task force","author":"Guirguis-Blake","year":"2018"},{"key":"10.1016\/j.afos.2023.06.002_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jot.2020.05.007","article-title":"The effectiveness of exercises on fall and fracture prevention amongst community elderlies: a systematic review and meta-analysis","volume":"24","author":"Wong","year":"2020","journal-title":"J Orthop Translat"},{"issue":"1","key":"10.1016\/j.afos.2023.06.002_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjsem-2019-000663","article-title":"Exercise for falls prevention in community-dwelling older adults: trial and participant characteristics, interventions and bias in clinical trials from a systematic review","volume":"5","author":"Ng","year":"2019","journal-title":"BMJ Open Sport Exerc Med"},{"key":"10.1016\/j.afos.2023.06.002_bib30","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1136\/bjsports-2016-096547","article-title":"Exercise to prevent falls in older adults: an updated systematic review and meta-analysis","volume":"51","author":"Sherrington","year":"2017","journal-title":"Br J Sports Med"},{"key":"10.1016\/j.afos.2023.06.002_bib31","first-page":"Cd012424","article-title":"Exercise for preventing falls in older people living in the community","volume":"1","author":"Sherrington","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.afos.2023.06.002_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s12877-020-01721-6","article-title":"Effectiveness of exercise intervention on fall-related fractures in older adults: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.afos.2023.06.002_bib34","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1532-5415.2010.03234.x","article-title":"Panel on prevention of falls in older persons, American geriatrics society and British geriatrics society. Summary of the updated American geriatrics society\/British geriatrics society clinical practice guideline for prevention of falls in older persons","volume":"59","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.afos.2023.06.002_bib35","series-title":"Position Statement on falls and fragility fractures","year":"2020"},{"key":"10.1016\/j.afos.2023.06.002_bib36","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12877-017-0492-6","article-title":"The design and development of a complex multifactorial falls assessment intervention for falls prevention: the Prevention of Falls Injury Trial (PreFIT)","volume":"17","author":"Bruce","year":"2017","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.afos.2023.06.002_bib37","article-title":"Interventions for preventing falls in older people living in the community","volume":"2012","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.afos.2023.06.002_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-019-05176-3","article-title":"Algorithm for the management of patients at low, high and very high risk of osteoporotic fracture","volume":"31","author":"Kanis","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib39","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.afos.2023.06.002_bib40","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.afos.2023.06.002_bib41","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s00198-004-1725-z","article-title":"Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women","volume":"16","author":"Papapoulos","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s00223-004-0005-4","article-title":"Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis","volume":"76","author":"Richy","year":"2005","journal-title":"Calcif Tissue Int"},{"issue":"3","key":"10.1016\/j.afos.2023.06.002_bib43","first-page":"Cd000227","article-title":"Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis","author":"Avenell","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.afos.2023.06.002_bib44","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1007\/s10067-020-05122-3","article-title":"A systematic review and meta-analysis of vitamin D and calcium in preventing osteoporotic fractures","volume":"39","author":"Eleni","year":"2020","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.afos.2023.06.002_bib45","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.afos.2023.06.002_bib46","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s10067-007-0824-6","article-title":"Monthly oral ibandronate is effective and well tolerated after 3 years: the MOBILE long-term extension","volume":"27","author":"Stakkestad","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.afos.2023.06.002_bib47","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.06.002_bib48","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.afos.2023.06.002_bib49","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1210\/jcem.87.8.8750","article-title":"Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial","volume":"87","author":"Delmas","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2023.06.002_bib50","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib51","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.afos.2023.06.002_bib52","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.afos.2023.06.002_bib53","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.afos.2023.06.002_bib54","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2019-00192","article-title":"Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis","volume":"104","author":"Barrionuevo","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2023.06.002_bib55","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.afos.2023.06.002_bib56","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.afos.2023.06.002_bib57","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/GME.0000000000000921","article-title":"The 2017 hormone therapy position statement of the North American Menopause Society","volume":"24","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/j.afos.2023.06.002_bib58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/13697137.2016.1196047","article-title":"Revised global consensus statement on menopausal hormone therapy","volume":"19","author":"de Villiers","year":"2016","journal-title":"Climacteric"},{"issue":"10","key":"10.1016\/j.afos.2023.06.002_bib59","article-title":"Short-term and long-term effects of tibolone in postmenopausal women","volume":"10","author":"Formoso","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.afos.2023.06.002_bib60","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006478317173","article-title":"Continued breast cancer risk reduction in postmenopausal women treated with Raloxifene: 4-Year results from the MORE trial","volume":"65","author":"Cauley","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.afos.2023.06.002_bib61","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jbmr.1719","article-title":"Incidence of atypical nontraumatic diaphyseal fractures of the femur","volume":"27","author":"Dell","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.06.002_bib62","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.afos.2023.06.002_bib63","first-page":"12","article-title":"Atypical femur fractures: current understanding and approach to management","volume":"21","author":"Tile","year":"2020","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.afos.2023.06.002_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.06.002_bib65","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","article-title":"Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur","volume":"362","author":"Black","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.afos.2023.06.002_bib66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.06.002_bib67","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.afos.2023.06.002_bib68","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.bone.2008.01.003","article-title":"Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis","volume":"42","author":"Rizzoli","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.afos.2023.06.002_bib69","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar2050","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role","volume":"8","author":"Capsoni","year":"2006","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.afos.2023.06.002_bib70","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.14219\/jada.archive.2011.0108","article-title":"Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs","volume":"142","author":"Hellstein","year":"2011","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.afos.2023.06.002_bib71","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.06.002_bib72","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/MLR.0000000000001294","article-title":"Duration of bisphosphonate drug holidays and associated fracture risk","volume":"58","author":"Curtis","year":"2020","journal-title":"Med Care"},{"key":"10.1016\/j.afos.2023.06.002_bib73","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","article-title":"Denosumab and bisphosphonates: different mechanisms of action and effects","volume":"48","author":"Baron","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.afos.2023.06.002_bib74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2017.08.003","article-title":"Discontinuation of denosumab therapy for osteoporosis: a systematic review and position statement by ECTS","volume":"105","author":"Tsourdi","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.afos.2023.06.002_bib75","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM Trial and its Extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.afos.2023.06.002_bib76","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00198-017-3919-1","article-title":"Observations following discontinuation of long-term denosumab therapy","volume":"28","author":"McClung","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib77","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1210\/jc.2019-00192","article-title":"Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis","volume":"104","author":"Barrionuevo","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2023.06.002_bib78","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1210\/jc.2011-3060","article-title":"Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis","volume":"97","author":"Murad","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2023.06.002_bib79","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1359\/jbmr.080805","article-title":"Femoral bone strength and its relation to cortical and trabecular changes after treatment with PTH, alendronate, and their combination as assessed by finite element analysis of quantitative CT scans","volume":"23","author":"Keaveny","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.06.002_bib80","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","article-title":"One year of alendronate after one year of parathyroid hormone for osteoporosis","volume":"353","author":"Black","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.afos.2023.06.002_bib81","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1359\/jbmr.081215","article-title":"Sequential treatment of severe postmenopausal osteoporosis after teriparatide: final results of the Randomized, Controlled European Study of Forsteo (EUROFORS)","volume":"24","author":"Eastell","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.06.002_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2022.101623","article-title":"The effect of osteoporosis treatment on bone mass","volume":"36","author":"Appelman-Dijkstra","year":"2022","journal-title":"Best Pract Res Clin Endocrinol Metabol"},{"key":"10.1016\/j.afos.2023.06.002_bib83","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/jbmr.3452","article-title":"Effects of 24 months of treatment with romosozumab followed by 12 months of denosumab or placebo in postmenopausal women with low bone mineral density: a randomized, double-blind, phase 2, parallel group study","volume":"33","author":"McClung","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.afos.2023.06.002_bib84","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.afos.2023.06.002_bib85","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1210\/jc.2017-02163","article-title":"A phase III randomized placebo-controlled trial to evaluate efficacy and safety of romosozumab in men with osteoporosis","volume":"103","author":"Lewiecki","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.afos.2023.06.002_bib86","volume":"vol. 9","year":"2018"},{"key":"10.1016\/j.afos.2023.06.002_bib87","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00198-012-2093-8","article-title":"Treatment failure in osteoporosis","volume":"23","author":"Diez-Perez","year":"2012","journal-title":"Osteoporos Int"},{"issue":"Suppl 2","key":"10.1016\/j.afos.2023.06.002_bib88","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/S1297-319X(10)70008-7","article-title":"Defining treatment failure in severe osteoporosis","volume":"77","author":"Confavreux","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.afos.2023.06.002_bib89","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jval.2010.11.010","article-title":"A meta-analysis of osteoporotic fracture risk with medication nonadherence","volume":"14","author":"Ross","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.afos.2023.06.002_bib90","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1530\/EJE-10-0015","article-title":"Approach to the patient with secondary osteoporosis","volume":"162","author":"Hofbauer","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.afos.2023.06.002_bib91","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s00198-011-1868-7","article-title":"The 25(OH)D level needed to maintain a favourable bisphosphonate response is \u226533 ng\/ml","volume":"23","author":"Carmel","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.afos.2023.06.002_bib92","doi-asserted-by":"crossref","DOI":"10.1038\/boneres.2017.21","article-title":"Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment","volume":"5","author":"Nakamura","year":"2017","journal-title":"Bone Res"}],"container-title":["Osteoporosis and Sarcopenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405525523000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405525523000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T07:35:26Z","timestamp":1762500926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405525523000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2405525523000316"],"URL":"https:\/\/doi.org\/10.1016\/j.afos.2023.06.002","relation":{},"ISSN":["2405-5255"],"issn-type":[{"value":"2405-5255","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A summary of the Malaysian Clinical Practice Guidelines on the management of postmenopausal osteoporosis, 2022","name":"articletitle","label":"Article Title"},{"value":"Osteoporosis and Sarcopenia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.afos.2023.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}